$134.00
0[0.00%]
At close: Apr 23
$134.00
0[0.00%]
PreMarket: 6:46PM EDT
DexCom reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of DexCom using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | PM | DXCM | Q1 | $0.17 | $0.27 | — | — | $741.50M | $910.04M | — | — | Get Alert |
02/08/2024 | PM | DXCM | Q4 | $0.34 | $0.43 | $0.50 | 16.28% | $815.20M | $1.02B | $1.03B | 1.42% | Get Alert |
10/26/2023 | PM | DXCM | Q3 | $0.28 | $0.34 | $0.50 | 47.06% | $769.60M | $939.24M | $975.00M | 3.81% | Get Alert |
07/27/2023 | PM | DXCM | Q2 | $0.17 | $0.23 | $0.34 | 47.83% | $692.20M | $841.62M | $871.30M | 3.53% | Get Alert |
04/27/2023 | PM | DXCM | Q1 | $0.08 | $0.15 | $0.17 | 13.33% | $628.80M | $720.74M | $741.50M | 2.88% | Get Alert |
02/09/2023 | PM | DXCM | Q4 | $0.17 | $0.27 | $0.34 | 25.93% | $698.20M | $809.65M | $815.20M | 0.69% | Get Alert |
10/27/2022 | PM | DXCM | Q3 | $0.22 | $0.24 | $0.28 | 16.67% | $650.20M | $751.71M | $769.60M | 2.38% | Get Alert |
07/28/2022 | PM | DXCM | Q2 | $0.19 | $0.19 | $0.17 | -10.53% | $595.10M | $698.55M | $692.20M | -0.91% | Get Alert |
04/28/2022 | PM | DXCM | Q1 | $0.08 | $0.13 | $0.08 | -38.46% | $505.00M | $623.36M | $628.80M | 0.87% | Get Alert |
02/10/2022 | PM | DXCM | Q4 | $0.23 | $0.21 | $0.17 | -19.05% | $568.90M | $695.63M | $698.20M | 0.37% | Get Alert |
10/28/2021 | PM | DXCM | Q3 | $0.24 | $0.16 | $0.22 | 37.50% | $500.90M | $617.82M | $650.20M | 5.24% | Get Alert |
07/29/2021 | PM | DXCM | Q2 | $0.20 | $0.11 | $0.19 | 72.73% | $451.80M | $551.27M | $595.10M | 7.95% | Get Alert |
04/29/2021 | PM | DXCM | Q1 | $0.11 | $0.08 | $0.08 | 0.00% | $405.10M | $484.23M | $505.00M | 4.29% | Get Alert |
02/11/2021 | PM | DXCM | Q4 | $0.29 | $0.23 | $0.23 | 0.00% | $462.80M | $552.23M | $568.90M | 3.02% | Get Alert |
10/27/2020 | PM | DXCM | Q3 | $0.16 | $0.16 | $0.24 | 50.00% | $396.30M | $476.75M | $500.90M | 5.07% | Get Alert |
07/28/2020 | PM | DXCM | Q2 | $0.02 | $0.09 | $0.20 | 122.22% | $336.40M | $415.39M | $451.80M | 8.77% | Get Alert |
04/28/2020 | PM | DXCM | Q1 | -$0.01 | $0.04 | $0.11 | 175.00% | $280.50M | $358.62M | $405.10M | 12.96% | Get Alert |
02/13/2020 | PM | DXCM | Q4 | $0.14 | $0.19 | $0.29 | 52.63% | $338.00M | $442.38M | $462.80M | 4.62% | Get Alert |
11/06/2019 | PM | DXCM | Q3 | $0.04 | $0.05 | $0.16 | 220.00% | $266.70M | $348.12M | $396.30M | 13.84% | Get Alert |
DexCom (DXCM) is scheduled to report earnings on April 25, 2024. The last reported earnings were for reported on February 8, 2024 for Q4.
The Actual EPS was $0.50, which beat the estimate of $0.43.
The Actual Revenue was $1B, which beat the estimate of $1B.
Browse earnings estimates, EPS, and revenue on all stocks.